Bohan Alan, Chen Wen-Sheng, Denson Lee A, Held Matthew A, Boyer James L
Yale Liver Center and Yale Child Health Research Center, Yale University School of Medicine, New Haven, Connecticut 06520-8019, USA.
J Biol Chem. 2003 Sep 19;278(38):36688-98. doi: 10.1074/jbc.M304011200. Epub 2003 Jul 1.
Mrp3(Abcc3) is markedly induced following bile duct ligation (BDL) in the rat and in some human cholestatic liver diseases and is believed to ameliorate liver injury in this setting. Recently, the orphan nuclear receptor fetoprotein transcription factor/cholesterol-7alpha-hydroxylase promoter factor (CPF/FTF/Lrh-1) has been shown to activate Mrp3 expression. However, whether inflammatory cytokines or elevated bile acid levels increased Lrh-1/Mrp3 expression in obstructive cholestasis was not known. We hypothesized that induction of Mrp3 would be associated with Lrh-1 up-regulation and would require intact cytokine signaling. Male tumor necrosis factor (Tnf) receptor I (Tnfr-/-) mice and C57BLJ wild type (WT) controls were subjected to sham surgery or bile duct ligation. HepG2 cells were treated with bile acids or cytokines. Immunoblot assay and real time reverse transcriptase-PCR were used to determine expression of MRP3/Mrp3, CPF/Lrh-1, Mrp2, and Bsep. CPF/Lrh-1 DNA binding to the MRP3/Mrp3 promoter was assessed using electrophoretic mobility shift assay, and promoter activity was determined by luciferase assay. Total bile acids and lactate dehydrogenase were measured using colorimetric assays, and cytokine abundance was determined by enzyme-linked immunosorbent assay. Lrh-1 and Mrp3 were significantly induced after BDL in WT but not Tnfr-/- mice. This was associated with more severe hepatocellular necrosis in Tnfr-/- mice. Lrh-1 binding to the Mrp3 promoter increased after BDL in WT but not in Tnfr-/- mice. Tnfalpha treatment of HepG2 cells also up-regulated CPF and MRP3, increased CPF binding to the MRP3 promoter, and up-regulated MRP3 promoter activity. These results indicate that induction of Mrp3 after BDL is due to Tnfalpha-dependent up-regulation of Lrh-1. They provide strong evidence that induction of Mrp3 plays a significant role in hepatocyte protection during obstructive cholestasis.
Mrp3(Abcc3)在大鼠胆管结扎(BDL)后以及一些人类胆汁淤积性肝病中显著上调,据信在这种情况下可改善肝损伤。最近,孤儿核受体甲胎蛋白转录因子/胆固醇7α-羟化酶启动子因子(CPF/FTF/Lrh-1)已被证明可激活Mrp3的表达。然而,在梗阻性胆汁淤积中,炎性细胞因子或升高的胆汁酸水平是否会增加Lrh-1/Mrp3的表达尚不清楚。我们推测,Mrp3的诱导与Lrh-1的上调有关,并且需要完整的细胞因子信号传导。雄性肿瘤坏死因子(Tnf)受体I(Tnfr-/-)小鼠和C57BLJ野生型(WT)对照接受假手术或胆管结扎。HepG2细胞用胆汁酸或细胞因子处理。采用免疫印迹分析和实时逆转录聚合酶链反应来测定MRP3/Mrp3、CPF/Lrh-1、Mrp2和Bsep的表达。使用电泳迁移率变动分析评估CPF/Lrh-1与MRP3/Mrp3启动子的DNA结合,并通过荧光素酶测定法确定启动子活性。使用比色法测量总胆汁酸和乳酸脱氢酶,并通过酶联免疫吸附测定法确定细胞因子丰度。BDL后,WT小鼠而非Tnfr-/-小鼠中Lrh-1和Mrp3显著诱导。这与Tnfr-/-小鼠中更严重的肝细胞坏死有关。BDL后,WT小鼠而非Tnfr-/-小鼠中Lrh-1与Mrp3启动子的结合增加。用Tnfα处理HepG2细胞也上调了CPF和MRP3,增加了CPF与MRP3启动子的结合,并上调了MRP3启动子活性。这些结果表明,BDL后Mrp3的诱导是由于Tnfα依赖性的Lrh-1上调。它们提供了强有力的证据,表明Mrp3的诱导在梗阻性胆汁淤积期间的肝细胞保护中起重要作用。